Skip to main content
Erschienen in: Archives of Virology 3/2008

01.03.2008 | Rapid Communication

Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine

verfasst von: T. Nakagomi, L. E. Cuevas, R. G. Gurgel, S. H. Elrokhsi, Y. A. Belkhir, M. Abugalia, W. Dove, F. M. U. Montenegro, J. B. Correia, O. Nakagomi, N. A. Cunliffe, C. A. Hart

Erschienen in: Archives of Virology | Ausgabe 3/2008

Einloggen, um Zugang zu erhalten

Abstract

The introduction of a G1P[8] rotavirus vaccine in Recife, Brazil, caused a decrease in rotavirus detection from 27% (March–May, 2006) to 5.0% (March–May, 2007), with all strains becoming G2, against which less protection had been predicted.
Literatur
1.
Zurück zum Zitat Araujo IT, Fialho AM, de Assis RM, M, Galvao M, Cruz CM, Ferreira MS, Leite JP (2002) Rotavirus strain diversity in Rio de Janeiro, Brazil: characterization of VP4 and VP7 genotypes in hospitalized children. J Trop Pediatr 48:214–218PubMedCrossRef Araujo IT, Fialho AM, de Assis RM, M, Galvao M, Cruz CM, Ferreira MS, Leite JP (2002) Rotavirus strain diversity in Rio de Janeiro, Brazil: characterization of VP4 and VP7 genotypes in hospitalized children. J Trop Pediatr 48:214–218PubMedCrossRef
2.
Zurück zum Zitat Bok K, Castagnaro N, Borsa A, Nates S, Espul C, Fay O, Fabri A, Grinstein S, Miceli I, Matson DO, Gomez JA (2001) Surveillance for rotavirus in Argentina. J Med Virol 65:190–198PubMedCrossRef Bok K, Castagnaro N, Borsa A, Nates S, Espul C, Fay O, Fabri A, Grinstein S, Miceli I, Matson DO, Gomez JA (2001) Surveillance for rotavirus in Argentina. J Med Virol 65:190–198PubMedCrossRef
3.
Zurück zum Zitat Castello A, Arvay M, Glass R, Gentsch J (2004) Rotavirus strain surveillance in Latin America: a review of the last nine years. Pediatr Infect Dis J 23(suppl):168–172CrossRef Castello A, Arvay M, Glass R, Gentsch J (2004) Rotavirus strain surveillance in Latin America: a review of the last nine years. Pediatr Infect Dis J 23(suppl):168–172CrossRef
4.
Zurück zum Zitat Cunliffe NA, Nakagomi O (2005) A critical time for rotavirus vaccines: a review. Expert Rev Vaccines 4:521–532PubMedCrossRef Cunliffe NA, Nakagomi O (2005) A critical time for rotavirus vaccines: a review. Expert Rev Vaccines 4:521–532PubMedCrossRef
5.
Zurück zum Zitat Estes MK, Kapikian AZ (2007) Rotavirus. In: Knipe DM, Howley PM (eds) Fields virology. 5th edn. vol 2. Lippincott Williams and Wilkins, Philadelphia, pp 1917–1974 Estes MK, Kapikian AZ (2007) Rotavirus. In: Knipe DM, Howley PM (eds) Fields virology. 5th edn. vol 2. Lippincott Williams and Wilkins, Philadelphia, pp 1917–1974
6.
Zurück zum Zitat Gentsch JR, Glass RI, Woods P, Gouvea V, Gorziglia M, Flores J, Das BK, Bhan MK (1992) Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol 30:1365–1373PubMed Gentsch JR, Glass RI, Woods P, Gouvea V, Gorziglia M, Flores J, Das BK, Bhan MK (1992) Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol 30:1365–1373PubMed
7.
Zurück zum Zitat Gouvea V, Glass RI, Woods P, Taniguchi K, Clark HF, Forreter B, Fang ZY (1990) Polymerase chain reaction amplification and typing of rotavirus nucleic acids from stool specimens. J Clin Microbiol 28:276–282PubMed Gouvea V, Glass RI, Woods P, Taniguchi K, Clark HF, Forreter B, Fang ZY (1990) Polymerase chain reaction amplification and typing of rotavirus nucleic acids from stool specimens. J Clin Microbiol 28:276–282PubMed
8.
Zurück zum Zitat Kapikian AZ, Hoshino Y (2007) To serotype or not to serotype: that is still the question. J Infect Dis 195:625–632CrossRef Kapikian AZ, Hoshino Y (2007) To serotype or not to serotype: that is still the question. J Infect Dis 195:625–632CrossRef
9.
Zurück zum Zitat Kutsuzawa T, Konno T, Suzuki H, Kapikian AZ, Ebina T, Ishida N (1982) Isolation of human rotavirus subgroups 1 and 2 in cell culture. J Clin Microbiol 16:727–730PubMed Kutsuzawa T, Konno T, Suzuki H, Kapikian AZ, Ebina T, Ishida N (1982) Isolation of human rotavirus subgroups 1 and 2 in cell culture. J Clin Microbiol 16:727–730PubMed
10.
Zurück zum Zitat Montenegro FM, Correia JB, Falbo AR, Dove W, Nakagomi T, Nakagomi O, Cuevas LE, Cunliffe NA, Hart CA (2007) Anticipating rotavirus vaccines in Brazil: detection and molecular characterization of emerging rotavirus serotypes G8 and G9 among children with diarrhea in Recife, Brazil. J Med Virol 79:335–340PubMedCrossRef Montenegro FM, Correia JB, Falbo AR, Dove W, Nakagomi T, Nakagomi O, Cuevas LE, Cunliffe NA, Hart CA (2007) Anticipating rotavirus vaccines in Brazil: detection and molecular characterization of emerging rotavirus serotypes G8 and G9 among children with diarrhea in Recife, Brazil. J Med Virol 79:335–340PubMedCrossRef
11.
Zurück zum Zitat Parashar UE, Gibson CJ, Bresee J, Glass R (2006) Rotavirus and severe childhood diarrhea. Emerg Infect Dis 12:304–306PubMed Parashar UE, Gibson CJ, Bresee J, Glass R (2006) Rotavirus and severe childhood diarrhea. Emerg Infect Dis 12:304–306PubMed
13.
Zurück zum Zitat Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, Cervantes Y, Linhares AC, Lopez P, Macias-Parra M, Ortega-Barria E, Richardson V, Rivera-Medina DM, Rivera L, Salinas B, Pavia-Ruz N, Salmeron J, Ruttimann R, Tinoco JC, Rubio P, Nunez E, Guerrero ML, Yarzabal JP, Damaso S, Tornieporth N, Saez-Llorens X, Vergara RF, Vesikari T, Bouckenooghe A, Clemens R, De Vos B, O’Ryan M; Human Rotavirus Vaccine Study Group (2006) Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 354:11–22PubMedCrossRef Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, Cervantes Y, Linhares AC, Lopez P, Macias-Parra M, Ortega-Barria E, Richardson V, Rivera-Medina DM, Rivera L, Salinas B, Pavia-Ruz N, Salmeron J, Ruttimann R, Tinoco JC, Rubio P, Nunez E, Guerrero ML, Yarzabal JP, Damaso S, Tornieporth N, Saez-Llorens X, Vergara RF, Vesikari T, Bouckenooghe A, Clemens R, De Vos B, O’Ryan M; Human Rotavirus Vaccine Study Group (2006) Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 354:11–22PubMedCrossRef
14.
Zurück zum Zitat Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, Shinefield HR, Christie CD, Ylitalo S, Itzler RF, Coia ML, Onorato MT, Adeyi BA, Marshall GS, Gothefors L, Campens D, Karvonen A, Watt JP, O’Brien KL, DiNubile MJ, Clark HF, Boslego JW, Offit PA, Heaton PM; Rotavirus Efficacy, Safety Trial (REST) Study Team (2006) Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 354:23–33PubMedCrossRef Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, Shinefield HR, Christie CD, Ylitalo S, Itzler RF, Coia ML, Onorato MT, Adeyi BA, Marshall GS, Gothefors L, Campens D, Karvonen A, Watt JP, O’Brien KL, DiNubile MJ, Clark HF, Boslego JW, Offit PA, Heaton PM; Rotavirus Efficacy, Safety Trial (REST) Study Team (2006) Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 354:23–33PubMedCrossRef
Metadaten
Titel
Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine
verfasst von
T. Nakagomi
L. E. Cuevas
R. G. Gurgel
S. H. Elrokhsi
Y. A. Belkhir
M. Abugalia
W. Dove
F. M. U. Montenegro
J. B. Correia
O. Nakagomi
N. A. Cunliffe
C. A. Hart
Publikationsdatum
01.03.2008
Verlag
Springer Vienna
Erschienen in
Archives of Virology / Ausgabe 3/2008
Print ISSN: 0304-8608
Elektronische ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-007-0028-z

Weitere Artikel der Ausgabe 3/2008

Archives of Virology 3/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.